Latest in Ozempiclike Drug

Sort by

6 items

Bain buys 340-year-old pharma company to fast-track Japan’s drug development

Private equity firm expects $3.3bn acquisition of Tanabe will get boost from eased approval process for new medicine
Financial Times - 14h

Topics